Well don't worry. Same doctor John Heymach will soon do another investor resenttion for Raj using his investigational study drama and SPPI will fool more invstora on POZIOTINIB being exon 20 mutation blockbuster. Its mazing that they use word BLOCKBUSTER for any failed compund from a third world country as if they are going to washroom.
Few Key news-
- John Heymach will give more fake news about POZIOTINIB in coming times but this drug will never come to floor as it's a trash compound bought from asn asian company who are masters at lying on SAEs. It's a failed compound. John's deal with Ran is unknown but external sources says roughly $4 million in cash and kinds through various ways.
- SPPIs thug fake Biostatistician and VP <Gajanan Bhat> boastd already mutliple time that he has cooked data on ROLANTIS under the pressure of CEO Raj as Raj wants to announce on ROLANTIS between Dec 15 to Mar 15. So be ready to hear more fake news on interim analysis. Take home message- enquire and make sure thourougjly investigate before putting you money to any place. Enquire about the backgrounds of people who are working on data and reputation of a company in market. Point to be noted is that Allergan Fired data manager Russell Kondo is working on ROLANTIS per Gajanan. Once can get all details about Russell's past from Allergan as people still talk about his work ethics here.
- SPPI has finally found a scapegoat person in their Data Management probably to save Gajanan Bhat (a highly defamed statistician) per various articles and forums online. Poor guy/girl will have to pay for Gajanan's sins.
- Anil Hiteshi aka 8 department VP in SPPI still remains the bigger JOKER and vulnerable point in SPPI. He knows all the lows and shades of CEO Raj and about SPPIs conduct and if FBI, SEC or FDA grills him tightly he will spill all the truth out.
- CEO Raj's housemaid made employee Chander Vasnandani is still not clear about his relationship with CEO as per various sources. Why he was brought from India and why he was made a Director right away is still not understood. During his employment he is still getting company paid accommodation for over an year now plus money under the table, a package beyond anybody, regilar visit to CEOs clubhouse etc. near Half of the SPPI hates him even after being awarded and promoted by CEO himself on many podiums. Something is very fishy and unethical here...
- CEO Raj has hired many low experienced kids and have made them managers all around the organization ..just to SPY for him. These are good kids under a bad person(CEO) and All this information is coming from some of them only.
- Newz of the decade from SPPI is that many of CEO Raj's high level VPs and Directors had planned and forced Raj to raise stock prices so they can also get some juice. Per these folks Raj was such a selfish person who used to keep all fruits for himself. Remember, stock of SPPI did not upp due to a drug being approved, positive phase -3 data or anything from inside. It got upped due to Raj being playing a hand with Dr. John Heymach showcasing great result of Poziotinib in just couple of patient inq so called investigators trial for marketing purpose. This theatrics costed CEO Raj approximately $4 million. FDA will have a keen eye on this drug in future plus SEC will keep a stringent eye on Raj, CPA and VP Kurt Gustafson, Shiv Kapoor and their combined acts.
